New Key Statistics Module, Z-Score and F-Score
NAS:BOLT Key Ratios
Market Cap $ M | 43.47 |
Enterprise Value $ M | -39.65 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.39 |
Price/Sales | 5.29 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 7.00 |
EPS (TTM) $ | -1.83 |
Beneish M-Score | -1.95 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -9.90 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | 0.52 |
EV-to-EBITDA | 0.53 |
PEG | -- |
Shares Outstanding M | 38.13 |
Net Margin (%) | -878.58 |
Operating Margin % | -967.45 |
Pre-tax Margin (%) | -878.58 |
Quick Ratio | 5.17 |
Current Ratio | 5.17 |
ROA % (ttm) | -36.05 |
ROE % (ttm) | -48.57 |
ROIC % (ttm) | -112.92 |
Dividend Yield % | -- |
Altman Z-Score | -3.39 |
Piotroski F-Score | 1.00 |
Positive ROA | N |
Positive CFROA | N |
Higher ROA y-y | N |
Cash flow > Earnings | N |
Lower Leverage y-y | N |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | N |
Higher Asset Turnover y-y | Y |
BOLT Number of Guru Trades
BOLT Volume of Guru Trades
Gurus Latest Trades with NAS:BOLT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BOLT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Bolt Biotherapeutics Inc Insider Transactions
No Available Data
News about NAS:BOLT
Total 0- 1